chr11-3218216-C-A
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The NM_001164377.1(MRGPRG):c.598G>T(p.Val200Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000654 in 1,529,032 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. V200L) has been classified as Uncertain significance.
Frequency
Consequence
NM_001164377.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MRGPRG | ENST00000332314.3 | c.598G>T | p.Val200Phe | missense_variant | Exon 1 of 1 | 6 | NM_001164377.1 | ENSP00000330612.3 | ||
MRGPRG-AS1 | ENST00000420873.2 | n.-172C>A | upstream_gene_variant | 2 | ||||||
MRGPRG-AS1 | ENST00000434798.1 | n.-116C>A | upstream_gene_variant | 2 | ||||||
MRGPRG-AS1 | ENST00000531711.1 | n.-151C>A | upstream_gene_variant | 4 |
Frequencies
GnomAD3 genomes AF: 0.0000264 AC: 4AN: 151412Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000146 AC: 2AN: 136622Hom.: 0 AF XY: 0.0000138 AC XY: 1AN XY: 72514
GnomAD4 exome AF: 0.00000436 AC: 6AN: 1377620Hom.: 0 Cov.: 32 AF XY: 0.00000443 AC XY: 3AN XY: 676794
GnomAD4 genome AF: 0.0000264 AC: 4AN: 151412Hom.: 0 Cov.: 32 AF XY: 0.0000271 AC XY: 2AN XY: 73924
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.598G>T (p.V200F) alteration is located in exon 1 (coding exon 1) of the MRGPRG gene. This alteration results from a G to T substitution at nucleotide position 598, causing the valine (V) at amino acid position 200 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at